Seattle Genetics is a company that is continuously appearing in the latest spotlights of therapeutic advances and news. Dr. Clay Siegall is the founder and CEO of the firm, and together with a team of sympathizers of science and researchers, the group is leading the front of discoveries and therapies in the combat against cancer.
Seattle Genetics is focused on one simple task that has changed thousands of treatments in the world: The development of drugs with high potential that can be used in therapies against disease like cancer that humanity is struggling to combat.
Seattle Genetics was founded in 1998 by the expert in genetics. He was studying the researches being made to combat diseases like cancer for many consecutive years.
Clay Siegall has decades of experience in the market and has a full degree in his field. He acquired his Bachelor’s degree in zoology from The University of Maryland and a Ph.D. in genetics from George Washington University, meaning that he has a complete understanding of the human genetics and the biological characteristics of animals and other beings.
One of the biggest achievements of Dr. Clay Siegall and the team was the development and release of the first FDA-approved antibody-drug conjugate, or “ADC.” Only three ADCs have received market approval by medicine to this date, and the triumph of Seattle Genetics in developing one that was extremely useful against a multitude of health issues was a big step for the fight against them. The drug that they were able to release in the market now has multiple approved indications by doctors and specialists.
Seattle Genetics did start from the ground under Dr. Siegall and the team’s leadership. It began as a small startup that aimed to renovate and revitalize drugs that assist medicine with heavy weaponry to try to stop the spreading and corruption of cancer and other benign and lethal diseases. Now, it is a leading force against cancer, all thanks to the Doctor’s dedication in finding the best experts internationally and making the fight against cancer his lifetime career.
Dr. Clay is part of the board of directors of Alder Biopharmaceuticals, where he gives his insight and knowledge about new drugs being developed, Mirna Therapeutics, and Fred Hutchinson Cancer Research Center, where he gathers and shares tons of information about cancer and the development of possible cure methods and treatments.